Products with Neuroprotection bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN2854 | Soyasaponin Ba |
| 1. Soyasaponins Ab and Bb prevent scopolamine-induced memory impairment in mice without the inhibition of acetylcholinesterase. 2. Soyasaponins(Aa, Ab, Af, Ba, Bb, and Bb') together with their derivatives may represent viable candidates for effective vaccine adjuvants due to their higher and lower or non-haemolytic effects. | |
| BCN2855 | 4',7-Isoflavandiol |
| 4',7-Isoflavandiol, an estrogen metabolite, affects the ability of soy nuts to improve cardiovascular risk factors. 4',7-Isoflavandiol is a potential anticancer agent against HeLa, with possible mechanisms involved in ROS generation and mitochondrial membrane alteration; it may advance breast cancer potential via up-regulation of the eukaryotic initiation factor 4GI (eIF4GI). | |
| BCN2893 | Tenuifoliside A |
| Tenuifoliside A has anti-apoptotic,neuroprotective,and anti-inflammatory effects, it inhibits the NF-κB and MAPK pathways. | |
| BCN2918 | Pratensein |
| 1. Pratensein has robust activation of acetylcholinesterase expression, the induction of acetylcholinesterase included the levels of mRNA, protein and enzymatic activity. 2. Pratensein can significantly ameliorate Aβ1-42-induced spatial learning and memory impairment through reducing neuroinflammation via inhibition of glial activation and NF-κB activation, and restoring synapse and BDNF levels, suggests that administration of pratensein could likely provide a therapeutic approach for AD. 3. Pratensein as a novel transcriptional up-regulator of scavenger receptor class B type I in HepG2 cells. 4. Pratensein can protect dopaminergic neurons against LPS-induced injury through inhibition of microglia activation and proinflammatory factors generation. | |
| BCN2922 | Jionoside A1 |
| 1. Jionoside A1 displays dose dependent immune-enhancement activity and possesses moderate neuroprotective activities on H2O2-treated SH-SY5Y cells. | |
